Hartford Investment Management CO Merck & Co., Inc. Transaction History

Hartford Investment Management CO

$2.88 Billion
Q2 2024

A detailed history of Hartford Investment Management CO transactions in Merck & Co., Inc. stock. As of the latest transaction made, Hartford Investment Management CO holds 162,231 shares of MRK stock, worth $18.4 Million. This represents 0.7% of its overall portfolio holdings.

Number of Shares

162,231

Previous 163,687 0.89%

Holding current value

$18.4 Million

Previous $21.6 Million 7.01%

% of portfolio

0.7%

Previous 0.77%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 01, 2024	SELL	$123.8 - $132.96 $180,252 - $193,589	-1,456 Reduced 0.89%	162,231 $20.1 Million
Q1 2024 Apr 17, 2024	SELL	$113.24 - $131.95 $797,322 - $929,059	-7,041 Reduced 4.12%	163,687 $21.6 Million
Q4 2023 Jan 23, 2024	SELL	$100.18 - $109.02 $371,868 - $404,682	-3,712 Reduced 2.13%	170,728 $18.6 Million
Q3 2023 Oct 16, 2023	SELL	$102.95 - $114.33 $518,147 - $575,422	-5,033 Reduced 2.8%	174,440 $18 Million
Q2 2023 Jul 19, 2023	SELL	$108.61 - $118.38 $3.86 Million - $4.2 Million	-35,502 Reduced 16.51%	179,473 $20.7 Million
Q1 2023 May 09, 2023	SELL	$102.94 - $114.86 $4.32 Million - $4.82 Million	-42,003 Reduced 16.34%	214,975 $22.9 Million
Q4 2022 Jan 20, 2023	SELL	$87.44 - $112.11 $89,626 - $114,912	-1,025 Reduced 0.4%	256,978 $28.5 Million
Q3 2022 Nov 02, 2022	BUY	$84.53 - $94.96 $165,340 - $185,741	1,956 Added 0.76%	258,003 $22.2 Million
Q2 2022 Jul 22, 2022	BUY	$83.49 - $94.64 $287,790 - $326,224	3,447 Added 1.36%	256,047 $23.3 Million
Q1 2022 Apr 20, 2022	SELL	$73.51 - $82.4 $1.3 Million - $1.46 Million	-17,712 Reduced 6.55%	252,600 $20.7 Million
Q4 2021 Feb 02, 2022	BUY	$72.28 - $90.54 $1.45 Million - $1.82 Million	20,089 Added 8.03%	270,312 $20.7 Million
Q3 2021 Nov 01, 2021	SELL	$71.68 - $78.83 $2.18 Million - $2.39 Million	-30,356 Reduced 10.82%	250,223 $18.8 Million
Q2 2021 Jul 29, 2021	SELL	$70.31 - $77.77 $422,844 - $467,708	-6,014 Reduced 2.1%	280,579 $21.8 Million
Q1 2021 Apr 21, 2021	SELL	$68.86 - $81.11 $667,528 - $786,280	-9,694 Reduced 3.27%	286,593 $22.1 Million
Q4 2020 Feb 01, 2021	BUY	$71.77 - $79.65 $2.11 Million - $2.34 Million	29,421 Added 11.02%	296,287 $24.2 Million
Q3 2020 Oct 29, 2020	SELL	$73.18 - $82.95 $705,162 - $799,306	-9,636 Reduced 3.48%	266,866 $22.1 Million
Q2 2020 Aug 04, 2020	SELL	$70.42 - $80.13 $1.91 Million - $2.18 Million	-27,144 Reduced 8.94%	276,502 $21.4 Million
Q1 2020 Apr 24, 2020	BUY	$63.36 - $87.82 $327,064 - $453,326	5,162 Added 1.73%	303,646 $23.4 Million
Q4 2019 Jan 29, 2020	SELL	$77.58 - $87.54 $611,795 - $690,340	-7,886 Reduced 2.57%	298,484 $27.1 Million
Q3 2019 Oct 28, 2019	SELL	$76.08 - $82.93 $3.34 Million - $3.64 Million	-43,907 Reduced 12.53%	306,370 $25.8 Million
Q2 2019 Jul 25, 2019	BUY	$69.84 - $81.59 $113,699 - $132,828	1,628 Added 0.47%	350,277 $29.4 Million
Q1 2019 Apr 29, 2019	BUY	$69.58 - $79.36 $341,707 - $389,736	4,911 Added 1.43%	348,649 $29 Million
Q4 2018 Feb 04, 2019	BUY	$65.24 - $75.71 $33,859 - $39,293	519 Added 0.15%	343,738 $26.3 Million
Q3 2018 Nov 08, 2018	SELL	$57.69 - $67.84 $616,590 - $725,073	-10,688 Reduced 3.02%	343,219 $24.3 Million
Q2 2018 Jul 19, 2018	SELL	$50.83 - $59.72 $9.4 Million - $11 Million	-184,906 Reduced 34.32%	353,907 $21.5 Million
Q1 2018 Apr 24, 2018	SELL	$50.96 - $59.23 $2.72 Million - $3.16 Million	-53,387 Reduced 9.02%	538,813 $29.3 Million
Q4 2017 Feb 12, 2018	SELL	$51.62 - $61.64 $1.38 Million - $1.65 Million	-26,787 Reduced 4.33%	592,200 $33.3 Million
Q3 2017 Nov 13, 2017	BUY	$58.67 - $63.13 $36.3 Million - $39.1 Million	618,987	618,987 $39.6 Million

Others Institutions Holding MRK

# of Institutions

3,830

Shares Held

1.91B

Call Options Held

13.4M

Put Options Held

10.7M

View Full List

About Merck & Co., Inc.

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $288B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

More about MRK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hartford Investment Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Hartford Investment Management CO with notifications on news.

Account

Hartford Investment Management CO Merck & Co., Inc. Transaction History